774 related articles for article (PubMed ID: 17102770)
1. New evidence for a role of allograft accommodation in long-term tolerance.
Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
4. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
[TBL] [Abstract][Full Text] [Related]
6. Propagation and characterization of lymphocytes from transplant biopsies.
Duquesnoy RJ; Trager JD; Zeevi A
Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
[TBL] [Abstract][Full Text] [Related]
7. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
[TBL] [Abstract][Full Text] [Related]
10. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade.
Matsui Y; Saiura A; Sugawara Y; Sata M; Naruse K; Yagita H; Kohro T; Mataki C; Izumi A; Yamaguchi T; Minami T; Sakihama T; Ihara S; Aburatani H; Hamakubo T; Kodama T; Makuuchi M
Physiol Genomics; 2003 Nov; 15(3):199-208. PubMed ID: 12966135
[TBL] [Abstract][Full Text] [Related]
11. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
[TBL] [Abstract][Full Text] [Related]
12. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
Semiletova NV; Shen XD; Slomowitz SJ; Baibakov B; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005; 37(1):35-6. PubMed ID: 15808538
[TBL] [Abstract][Full Text] [Related]
13. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance.
Hanidziar D; Koulmanda M
Curr Opin Organ Transplant; 2010 Aug; 15(4):411-5. PubMed ID: 20613526
[TBL] [Abstract][Full Text] [Related]
15. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
17. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
18. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
[TBL] [Abstract][Full Text] [Related]
20. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]